Pure Extracts Applies For Dealers License With Health Canada
Pure Extracts (CSE: PULL) continues to focus on the development of its mushroom-related operations in addition to cannabis. The company this morning announced that it ahs submitted an application for its Dealer’s License to Health Canada.
Submitted by the firms wholly owned subsidiary, Pure Mushrooms Corp, the license will enable a number of activities to be conducted by the company. Such activities include the procurement of controlled substances, which includes both the import and the production of substances such as psilocybin mushrooms, as well as the research and manufacture of controlled substances, the business to business sale of such substances, and the sale of controlled substances via pharmacies.
The license, if granted, will enable the firm to work on the research and development of extraction process of controlled substances, and will enable the firm to prepare to work with partners such as medical doctors, pharmaceutical firms and pharmacies. It’ll also enable Pure to be involved in the realm of clinical trials as a supplier of such controlled substances.